Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Controlled Prospective, Explorative Clinical Trial to Assess Pharmacology and Effectiveness of Echinaforce Chewable Tablets "EC" to Prevent From Enveloped Virus Infections

NCT05002179 is registered in ClinicalTrials.gov with A. Vogel AG as lead sponsor.

NCT NCT05002179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05002179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Controlled Prospective, Explorative Clinical Trial to Assess Pharmacology and Effectiveness of Echinaforce Chewable Tablets "EC" to Prevent From Enveloped Virus Infections
Lead sponsor
A. Vogel AG
Phase
Phase 4
Overall status
Completed
Start date
November 20, 2020
Completion date
May 29, 2021
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, respiratory tract infections